Documents

This position statement deals with alignment, enabling technologies, patient dissatisfaction and malalignment in total knee arthroplasty.

This position statement deals with the simultaneous and staged bilateral Total Knee Replacement (TKR).

This position statement deals with Operative and Non-operative Management in Anterior Cruciate Ligament (ACL) Injury.

This position statement deals with the Short Stay model of a reduced period inpatient stay after Hip and Knee Arthroplasty in Australia.

This position statement deals with inpatient rehabilitation, out-patient rehabilitation and self-directed rehabilitation after Hip and Knee Arthroplasty in Australia.

Currently under review. This position statement was developed by the Arthroplasty Society of Australia (ASA) in collaboration with the Australian Knee Society (AKS), both being Subspecialist Groups within the auspices of the Australian Orthopaedic Association (AOA).

The AKS and ASA endorse the statement from the International Consensus Meeting on Musculoskeletal Infection (ICMMI 2018) supporting the use of sterile dilute Povidone-iodine for the irrigation of wounds during surgical procedures. Surgeons are encouraged to refer to the ICMMI document for further reading: https://icmphilly.com 

In preparing the following evidence based document, the Australian Knee Society, on behalf of the Australian Orthopaedic Association, has combined the individual clinical expertise of its members with published randomized controlled trials from a systematic review of the literature.

In preparing the following evidence based document, the Australian Knee Society, on behalf of the Australian Orthopaedic Association, has combined the individual clinical expertise of its members with published randomized controlled trials from a systematic review of the literature.

The Australian Knee Society (AKS) is concerned about the increasing use of the LARS device for anterior cruciate ligament reconstruction in the absence of sufficient evidence to support its widespread use.

In 2010 the AKS was consulted to provide guidance to the Australian Orthopaedic Association on what advice it may give, if asked by any of its members, or members of the public, any questions regarding the burgeoning use of the LARS device for ACL reconstructive surgery. A survey of AKS members was conducted in December 2010. As a result of that survey, a position statement was developed in March 2011.